| | |
I-C vs. placebo
|
---|
|
N
|
Adjusteda mean (SE)
|
Adjusteda mean (SE) differenceb
|
95 % CI
|
p-value*
|
---|
SSS2–4
| | | | | |
I-C
|
98
|
1.12 (0.10)
|
−0.18 (0.15)
|
(-0.46, 0.11)
|
0.2310
|
Placebo
|
97
|
1.30 (0.10)
| | | |
LSS2–4
| | | | | |
I-C
|
98
|
4.66 (0.22)
|
−0.44 (0.30)
|
(-1.04, 0.16)
|
0.1465
|
Placebo
|
97
|
5.10 (0.22)
| | | |
AUC-TSS1–10
| | | | | |
I-C
|
98
|
41.94 (2.19)
|
0.73 (3.10)
|
(-5.39, 6.85)
|
0.8148
|
Placebo
|
97
|
41.21 (2.20)
| | | |
-
CI confidence interval, SE standard error
- *For ANCOVA-adjusted comparison of placebo with I-C
-
aThe means were adjusted for baseline SSS, LSS, or TSS
-
bA negative treatment difference favored I-C